Related to the above issue, in all longitudinal projects there will be attrition. Is there any estimate (for example based on the experiences of PETS) how many mothers will be dropped out during the follow up (having a baby and especially twin babies is a major change in life and even many motivated mothers may find it too labor to participate in a study after the delivery). Are there some measures to encourage participation during the follow-up?
When translating questionnaires to another language, the golden standard is back translation. This means that the translated questionnaires will be translated from Mandarin back to English by a different translator, and this translation is then compared to the original English questionnaire. This is a small investment but would confirm that the questionnaires are comparable.
I found it a bit strange that also triplet (or higher order) pregnancies are included. They differ a lot from twin (and of course even more from singleton) pregnancies. They are very rare and so there will probably be only a few (if any) this type of pregnancies among the participating mothers. So they need to be excluded anyway in most of the analyses, and having them thus only decreases the final sample size.
There is unnecessary overlap in inclusion and exclusion criteria (for example it is self-evident that if multiple pregnancy is an inclusion criteria then singleton pregnancies are excluded).
There are grammatical errors in the manuscript and also the message would become clearer if some sentences would be edited. Some terms are also strangely used (for example talking about the gestational age of infants sounds strange since infant means a newborn baby). Also saying that the inclusion criteria is that the mother is able to provide informed consent sounds strange (many mothers are able provide informed consent but for some reason do not want to do it). The manuscript would thus benefit on language editing.
REVIEWER

Marcus Pembrey Emeritus Professor of Paediatric Genetics
Great Ormond Street Institute of Child Health, University College London, UK REVIEW RETURNED 13-Jun-2017
GENERAL COMMENTS
It is a well designed, well written protocol concerning this important longitudinal study of twins. The only suggestion, given the reference to the importance of the microbiota in DOHaD studies [line 46, page 6] is to add the absence of microbiota data collection to the limitations listed on page 3
REVIEWER
Patrik Magnusson
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden REVIEW RETURNED 17-Aug-2017
GENERAL COMMENTS
The protocol describes an interesting and promising approach to establish a longitudinal twin study in China covering the critical in utero / new born / toddler time.
It relies on previous experiences from the Australian PETS study with similar design. Recruitment has been ongoing since November 2015 and is expected to stop in December 2017. The ambition is then to gather data from 12 visits by the mother and the twins over a time-span of 3 years plus the pregnancy time. The selected questionnaire instruments are plentiful but appear adequate for the research questions. The focus and design is of large interest since it may provide unique opportunity to test if associations between exposures remain also after controlling for genetic factors. Also, effects arising from in utero growth restriction and birth complications are of particular relevance among twins.
The number of measurements performed is very extensive while the target sample size is limited (300 pairs). Within-pair analyses are attractive from a conceptual point of view but are unfortunately generally associated with limited statistical power. Several childhood diseases and health problems occur at a rate of few percent. This means that there may be just single or handful pairs informative for most diseases. Thus, the statistical power might be inadequate for most such outcomes. However, for quantitative outcome measures with exposures of considerable effect, the data may be highly informative. I think the protocol should better describe what outcomes are in focus, with examples. I assume that PETS might serve as guidance.
Epigenetics is today usually undertaken globally (with chip technology) with several (hundreds) thousand markers. My experience is that effects are small and partially driven from first order genetics. I strongly doubt that the statistical power for global epigenetic investigations will be enough with a sample of 300 twin pairs, in particular if discordant within pair is the main approach. I suggest that it should be mentioned that the material may be most appropriate for performing within pair analyses of specific associations already established elsewhere.
Buccal swabs are intended for sample collection of DNA for genetic and epigenetic approaches. I think this is fine for genetics but wonder what the advantage is for epigenetics? I suspect that cell type composition may vary extensively between subjects (leukocytes vs epithelial cells) in buccal swab samples. Why not use some of the blood for epigenetics? I suggest this is discussed.
In the background section of the protocol the authors mention that microbiota sampling is considered essential in any modern cohort aiming to explore DOHaD causal pathways. Still there is no description of such collections/measurements which appears inconsistent. Either include information about how microbiota should be accessed or remove the sentence.
How should the MZ enrichment be done? Ultrasound detected opposite sexed DZ exclusion could be one method. The strategy needs to be described. I cannot find anything about collection of data on prescribed medicines. Should this not be included?
The paper contains some typos and English language imperfections which should not be very hard to correct.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1
In Introduction, the authors discuss many aspects of twins and twin design, but it lacks the discussion probably the most important aspect for the current project, i.e., the different intrauterine environments of co-twins.
Response: We have now addressed this by adding the following text to the introduction: 'Of particular note, we and others have demonstrated the importance of non-shared environments of twins in utero, particularly the effects of maternal and nutrient supply line factors (eg. placental structure, umbilical cord insertion point) on neonatal epigenetic profile. These effects appear tissue-and locus-specific emphasizing that responsiveness to environmental exposures in utero cannot be generalized. Such complexity in responsiveness to environmental exposures in utero has implications for any study investigating the developmental origins of health and disease. {Loke, 2013 #80}' Comment: Some rationality would be needed why exactly 300 pairs are selected as the sample size.
Is it based on power calculations or available resources?
Response: The number of twins chosen in this study was based solely on pragmatic reasoning. The cohort was funded by the National Natural Science Foundation for 5 years, including 2 years of recruitment, up to 3 years postnatal follow up and data reporting. Based on the number of twins currently born annually in CMU, 300 pairs, enriched for MZ twins was considered the maximum likely to be available.
Comment: Related to the above issue, in all longitudinal projects there will be attrition. Is there any estimate (for example based on the experiences of PETS) how many mothers will be dropped out during the follow up (having a baby and especially twin babies is a major change in life and even many motivated mothers may find it too labor to participate in a study after the delivery). Are there some measures to encourage participation during the follow-up?
Response: We have added the following text to the protocol detailing incentives used to maximise retention in the cohort. 'In order to maximise retention in the study postnatally several incentives will be offered including; 1) Free registration at paediatric clinics, 2) free phenotyping such as allergy screening and neurocognitive testing, 3) reimbursement of transportation costs and 4) access to 'green channel' in the hospital, abolishing waiting times. '
Comment: When translating questionnaires to another language, the golden standard is back translation. This means that the translated questionnaires will be translated from Mandarin back to English by a different translator, and this translation is then compared to the original English questionnaire. This is a small investment but would confirm that the questionnaires are comparable. Response: We did not feel this was necessary given that most of the questionnaires used in this study are either originally published in Chinese, or the published Chinese version of the original questionnaires. The Sleep questionnaire is the only one translated from English into Chinese by us.
Response: This is a good point and has been incorporated into the manuscript as follows. 'Women with a single pregnancy or multiples higher than twins (triplets etc)' is now included in the exclusion criteria Comment: There is unnecessary overlap in inclusion and exclusion criteria (for example it is selfevident that if multiple pregnancy is an inclusion criteria then singleton pregnancies are excluded). 'Singleton pregnancies' and 'women more than 16 weeks pregnant' have been deleted from the exclusion criteria
Response: This has now been addressed in the manuscript by removal of twins as an inclusion criteria
Comment: There are grammatical errors in the manuscript and also the message would become clearer if some sentences would be edited.
Response: Our English team have reread the manuscript and corrected any errors. These are identifiable using track changes. 'Women able to provide written informed consent' in the inclusion criteria has been reworded to 'Capacity to provide written, informed consent'
Reviewer: 2
Comment: The only suggestion, given the reference to the importance of the microbiota in DOHaD studies [line 46, page 6] is to add the absence of microbiota data collection to the limitations listed on page 3
Response: we have included this as suggested 'No samples for profiling the gut microbiome will be collected'
Reviewer: 3
Comment: Several childhood diseases and health problems occur at a rate of few percent. This means that there may be just single or handful pairs informative for most diseases. Thus, the statistical power might be inadequate for most such outcomes.
Response: As mentioned by the reviewer, quantitative outcome measures with exposures of considerable effect are likely to be highly informative. We have added the following text to the AIMS section of the protocol to make it clearer that we are interested in such measures. 'Given the size and duration of the initial phase of the study, we will focus on quantitative outcomes (continuous variables) often showing discordance within young twin pairs. This includes measures of growth and adiposity, body composition, allergic and neurodevelopmental outcomes all thought to involve environmental modulation of underlying genetic risk. Exposure, outcome and molecular data generated during this study will be analysed using standard twin modelling to partition variance into genetic, shared and non-shared environments.'
Comment: Epigenetics is today usually undertaken globally (with chip technology) with several (hundreds) thousand markers. My experience is that effects are small and partially driven from first order genetics. I strongly doubt that the statistical power for global epigenetic investigations will be enough with a sample of 300 twin pairs, in particular if discordant within pair is the main approach. I suggest that it should be mentioned that the material may be most appropriate for performing within pair analyses of specific associations already established elsewhere.
Response: We fully agree that epigenetic variation associated with specific phenotypes is anticipated to be modest and will be influenced by underlying genetics. This is why we are particularly focussed on within pair MZ comparisons, exploring the link between non-shared environment on quantitative phenotypes (such as growth) INDEPENDENT of underlying genetic variation between siblings. This is a major strength of the current study in that it negates the need for large sample sizes. Indeed, many of the major findings in the area have analysed very few discordant MZ pairs. This will certainly include an analysis of previous findings. 
GENERAL COMMENTS
My points have been adequately addressed.
VERSION 2 -AUTHOR RESPONSE
Response: This is a good point and has been incorporated into the manuscript as follows. 'Women with a single pregnancy or multiples higher than twins (triplets etc)' is now included in the exclusion criteria
Comment: There is unnecessary overlap in inclusion and exclusion criteria (for example it is selfevident that if multiple pregnancy is an inclusion criteria then singleton pregnancies are excluded). 'Singleton pregnancies' and 'women more than 16 weeks pregnant' have been deleted from the exclusion criteria
Response: This has now been addressed in the manuscript by removal of twins as an inclusion criteria Comment: There are grammatical errors in the manuscript and also the message would become clearer if some sentences would be edited.
The only suggestion, given the reference to the importance of the microbiota in DOHaD studies [line 46, page 6] is to add the absence of microbiota data collection to the limitations listed on page 3
Response: As mentioned by the reviewer, quantitative outcome measures with exposures of considerable effect are likely to be highly informative. We have added the following text to the AIMS section of the protocol to make it clearer that we are interested in such measures. 'Given the size and duration of the initial phase of the study, we will focus on quantitative outcomes (continuous variables) often showing discordance within young twin pairs. This includes measures of growth and adiposity, body composition, allergic and neurodevelopmental outcomes all thought to involve environmental modulation of underlying genetic risk. Exposure, outcome and molecular data generated during this study will be analysed using standard twin modelling to partition variance into genetic, shared and non-shared environments.' Comment: Epigenetics is today usually undertaken globally (with chip technology) with several (hundreds) thousand markers. My experience is that effects are small and partially driven from first order genetics. I strongly doubt that the statistical power for global epigenetic investigations will be enough with a sample of 300 twin pairs, in particular if discordant within pair is the main approach. I suggest that it should be mentioned that the material may be most appropriate for performing within pair analyses of specific associations already established elsewhere.
Response: We fully agree that epigenetic variation associated with specific phenotypes is anticipated to be modest and will be influenced by underlying genetics. This is why we are particularly focussed on within pair MZ comparisons, exploring the link between non-shared environment on quantitative phenotypes (such as growth) INDEPENDENT of underlying genetic variation between siblings. This is a major strength of the current study in that it negates the need for large sample sizes. Indeed, many of the major findings in the area have analysed very few discordant MZ pairs. This will certainly include an analysis of previous findings.
Comment: Buccal swabs are intended for sample collection of DNA for genetic and epigenetic approaches. I think this is fine for genetics but wonder what the advantage is for epigenetics? I suspect that cell type composition may vary extensively between subjects (leukocytes vs epithelial cells) in buccal swab samples. Why not use some of the blood for epigenetics? I suggest this is discussed.
Response: we and others have shown that buccal swabs collected at birth contain generally >90% epithelial cells (not shown)
Comment: In the background section of the protocol the authors mention that microbiota sampling is considered essential in any modern cohort aiming to explore DOHaD causal pathways. Still there is no description of such collections/measurements which appears inconsistent. Either include information about how microbiota should be accessed or remove the sentence.
Response: We have removed this text from the background section Comment: How should the MZ enrichment be done? Ultrasound detected opposite sexed DZ exclusion could be one method. The strategy needs to be described.
Response: We have now included the following text in methods: 'Where there is clear evidence of opposite sex DZ twins by ultrasound, these can be excluded from the study. Further, following birth, PCR-STR (short tandem satellite repeats) is performed to identity the zygosity in all same-sex twins. These can also be excluded from subsequent follow ups as a strategy to enrich the twin cohort for MZ twin pairs.'
Comment: I cannot find anything about collection of data on prescribed medicines. Should this not be included?
Response: Following text added: 'We are collecting information of medication use around the time of pregnancy and history of diseases at the time of recruitment. Medication prescription during pregnancy is also being recorded.'
